Home/Filings/4/0001235802-18-000162
4//SEC Filing

Cooke Peter 4

Accession 0001235802-18-000162

CIK 0001492658other

Filed

Nov 8, 7:00 PM ET

Accepted

Nov 9, 4:16 PM ET

Size

13.9 KB

Accession

0001235802-18-000162

Insider Transaction Report

Form 4
Period: 2018-11-08
Cooke Peter
President, International
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-11-0812,74717,620 total
    Exercise: $20.62Exp: 2025-10-13Ordinary Shares (12,747 underlying)
  • Exercise/Conversion

    Ordinary Shares, par value EUR 0.03 per share

    2018-11-08$20.62/sh+12,747$262,84339,209 total
  • Exercise/Conversion

    Ordinary Shares, par value EUR 0.03 per share

    2018-11-08$21.24/sh+982$20,85840,191 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-11-0898213,949 total
    Exercise: $21.24Exp: 2026-07-19Ordinary Shares (982 underlying)
  • Sale

    Ordinary Shares, par value EUR 0.03 per share

    2018-11-08$29.28/sh20,662$605,07419,529 total
Footnotes (5)
  • [F1]These shares were exercised and sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934.
  • [F2]Includes 10,666 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan and 8,863 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.05 to $29.90, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  • [F4]This option vests with respect to 25% of the shares on October 13, 2016 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.
  • [F5]This option vests with respect to 25% of the shares on July 19, 2017 and with respect to the remaining 75% of such shares over the three-year period thereafter in 36 as nearly equal as possible monthly installments.

Issuer

Wright Medical Group N.V.

CIK 0001492658

Entity typeother

Related Parties

1
  • filerCIK 0001577002

Filing Metadata

Form type
4
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 4:16 PM ET
Size
13.9 KB